A trifecta of slow wage growth, elevated interest rates, and heavy borrowing by the average household has weakened the spending impulse of more than 300 million families
Pidilite stock price has broken out from the downward sloping trend line on the weekly chart. Stock has surpassed the previous swing high resistance
IT Index is trading at 33,880.85 and is currently exhibiting a range-bound pattern on the charts. The defined range for this index lies between 34,300 and 32,700
Retail index long positions as on May 27, 2024 - five days ahead of vote counting - stood at 3.13 lakh contacts, as compared to 1.92 lakh contracts and 1.99 lakh contracts during such earlier periods
These units will be issued to sponsors or associates upon acquisition of an infrastructure project. Just like mutual funds, which are pooled investments, InvITs too issue units
Indian equities have been jittery amidst the ongoing elections and selling by foreign portfolio investors
Though buoyant on bourses, their earnings, sales have lagged overall listed universe in past 2 yrs
As corporate capex picks up, it expects the Indian corporate sector to sustain 12 - 17 per cent earnings growth in the medium-term
The court seeks reply from Sebi, NSE on the plea
Stock Market Highlights on May 28, 2024: The losses were steeper in the broader markets where the BSE MidCap fell 0.63 per cent, and the BSE SmallCap slipped 1.09 per cent
Sovereign bonds have already rallied in recent weeks, boosted by a reduction in short-term borrowings
Shares of Odyssey Technologies have locked in upper circuit of 20 per cent at Rs 156.97, also its 52-week high on the BSE on Tuesday at 01:30 pm; amid heavy volumes
Lok Sabha elections and markets: From a 52-week low of 8.4, India VIX has soared 191 per cent to over 24 levels now. In one month, it has sprinted 124 per cent
Indian government bonds are set to be included in the JPMorgan Emerging Market local currency debt index from June 28
Goodyear India's net loss stood at Rs 4.2 crore in the March quarter of financial year 2024 (Q4FY24), as opposed to net profit of Rs 33.6 crore in the same quarter a year ago (Q4FY23)
With improved macroeconomic indicators, enhanced government spending, a favorable monsoon forecast and moderate retail inflation, the upcoming year holds promise for a gradual uptick in consumption.
On Monday, Natco Pharma reported a 40.1 per cent year-on-year (YoY) surge in net profit, totaling Rs 386.3 crore in Q4FY23, up from Rs 275.8 crore
Analysts say that despite OAI on Eugia unit-III, Aurobindo Pharma's Vizag facility may play a back up for unit-III and for new ANDA filings contributing to growth in FY26
The state-owned company's profit plunged 37.8 per cent to Rs 1,412.7 crore in the March quarter of financial year 2024 (Q4FY24), from Rs 2,271.5 crore in Q4FY23
Jubilant Industries saw a 128 per cent increase in its net profit, amounting to Rs 22 crore in Q4FY24 from Rs 9.7 crore year-on-year